Overview

Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

Status:
Recruiting

Trial end date:
2024-05-22

Target enrollment:

Participant gender:

Summary

To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult patients.

Phase:

N/A

Details

Lead Sponsor:

Sight Sciences, Inc.

Treatments:

Cyclosporine
Cyclosporins